Category Archives: Smoking cessation

FDA Removes Black Box Warning On Smoking Cessation Medications

The FDA has determined that the risk of serious side effects on mood, behavior, or thinking with the smoking cessation medicines varenicline and bupropion is lower than previously suspected.  Following case reports of serious changes in mood and behavior in … Continue reading

Posted in Addiction, Drugs, Smoking cessation | Comments Off on FDA Removes Black Box Warning On Smoking Cessation Medications

Sixth Annual Chair Summit Begins This Week

This week a Master Class for Neuroscience Development called the Chair Summit takes place in Tampa, FL (Sept 26-28, 2013). In the early days of medical training in Kos, students, trainees and medical colleagues would gather to discuss their cases … Continue reading

Posted in Addiction, ADHD, Antipsychotic medication, Anxiety Disorders, Biomarker, Bipolar Disorder, Cardiovascular Risk Factors, Chronic Pain, CME, Dementia, Depression, Diabetes, Diagnosis, Digital medicine, Drug Development, Drugs, DSM-5, Early intervention, Education, Food, Genetics, Guideline, Imaging, Maintenance of Certification, Measurement-based care, Medical Education, Mood, MRI, Multiple sclerosis, Negative symptoms, Neuroscience, Obesity, Opioids, PET, Practice guideline, Psychosis, PTSD, Research, Schizophrenia, Smoking cessation, Social media, Stroke, Substance abuse, Transcranial magnetic stimulation, Vascular dementia | Comments Off on Sixth Annual Chair Summit Begins This Week

Preventing Smoking Relapse via Web-Based Computer Feedback

A study in the Journal of Medical Internet Research demonstrated that Web-based computer-tailored programs combined with planning strategy assignments and feedback after the quit attempt can be effective in preventing relapse 12 months after baseline.[More…]

Posted in Internet, News, Smoking cessation, Technology, Treatment | Comments Off on Preventing Smoking Relapse via Web-Based Computer Feedback